OraSure Wins Contract to Supply “Together Take Me Home,” HIV Self-Testing Initiative Sponsored by the Centers for Disease Control and Prevention
BETHLEHEM, Pa., Sept. 20, 2022 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ:OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that the Company has been selected to provide its OraQuick® In-Home HIV tests in support of the Centers for Disease Control and Preventions (CDC) “Together Take Me Home,” HIV self-test program. Under the program, the CDC will provide $41.5 million over a five-year period to support community testing. Emory University will manage the program and closely collaborate with a number of partner organizations, including OraSure, to supply tests to communities not equitably reached by HIV testing services across the United States.
Related news for (OSUR)
- OraSure Technologies Acquires Sherlock Biosciences
- orasure technologies elects jack kenny to the board of directors
- OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company
- OraSure to Participate in Upcoming Investor Conferences
- OraSure Technologies Continues its Dedication to Ending the HIV Epidemic